Manolete Partners Plc (MANOF)
| Market Cap | 44.05M |
| Revenue (ttm) | 39.38M |
| Net Income (ttm) | 1.15M |
| Shares Out | n/a |
| EPS (ttm) | 0.03 |
| PE Ratio | 38.18 |
| Forward PE | 14.46 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,000 |
| Average Volume | 16,370 |
| Open | 1.040 |
| Previous Close | 1.100 |
| Day's Range | 1.040 - 1.040 |
| 52-Week Range | 0.890 - 1.260 |
| Beta | 0.65 |
| RSI | n/a |
| Earnings Date | Aug 19, 2025 |
About Regulus Therapeutics
Manolete Partners Plc operates as an insolvency litigation financing company in the United Kingdom. It is involved in the acquisition and funding of insolvency litigation cases. The company was founded in 2009 and is headquartered in London, the United Kingdom. [Read more]
Financial Performance
In 2024, Manolete Partners's revenue was 30.48 million, an increase of 15.92% compared to the previous year's 26.30 million. Earnings were 893,000, a decrease of -4.29%.
Financial StatementsNews
Manolete Partners: When A Profit Warning Is A Good Thing
I have written about Manolete Partners previously and I believe that the investment thesis is now stronger than ever. On Friday 9th September 2022 the company issued a profit warning, but unusually th...
Litigation Finance: The VCs Of The Justice System
Litigation Finance is a rapidly growing industry that advantages first movers.
Manolete Partners Unlocks Explosive Growth
FY21 annual reports just published demonstrate that growth momentum is continuing at an impressive rate. Completed cases increased 150% YoY and realised revenue increased 214% YoY.